Unknown

Dataset Information

0

Design, synthesis, in silico studies and in vitro evaluation of isatin-pyridine oximes hybrids as novel acetylcholinesterase reactivators.


ABSTRACT: Organophosphorus poisoning caused by some pesticides and nerve agents is a life-threating condition that must be swiftly addressed to avoid casualties. Despite the availability of medical countermeasures, the clinically available compounds lack a broad spectrum, are not effective towards all organophosphorus toxins, and have poor pharmacokinetics properties to allow them crossing the blood-brain barrier, hampering cholinesterase reactivation at the central nervous system. In this work, we designed and synthesised novel isatin derivatives, linked to a pyridinium 4-oxime moiety by an alkyl chain with improved calculated properties, and tested their reactivation potency against paraoxon- and NEMP-inhibited acetylcholinesterase in comparison to the standard antidote pralidoxime. Our results showed that these compounds displayed comparable in vitro reactivation also pointed by the in silico studies, suggesting that they are promising compounds to tackle organophosphorus poisoning.

SUBMITTER: Kitagawa DAS 

PROVIDER: S-EPMC8219220 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design, synthesis, <i>in silico</i> studies and <i>in vitro</i> evaluation of isatin-pyridine oximes hybrids as novel acetylcholinesterase reactivators.

Kitagawa Daniel A S DAS   Rodrigues Rafael B RB   Silva Thiago N TN   Dos Santos Wellington V WV   da Rocha Vinicius C V VCV   de Almeida Joyce S F D JSFD   Bernardo Leandro B LB   Carvalho-Silva Taynara T   Ferreira Cintia N CN   da Silva Angelo A T AAT   Simas Alessandro B C ABC   Nepovimova Eugenie E   Kuča Kamil K   França Tanos C C TCC   Cavalcante Samir F de A SFA  

Journal of enzyme inhibition and medicinal chemistry 20211201 1


Organophosphorus poisoning caused by some pesticides and nerve agents is a life-threating condition that must be swiftly addressed to avoid casualties. Despite the availability of medical countermeasures, the clinically available compounds lack a broad spectrum, are not effective towards all organophosphorus toxins, and have poor pharmacokinetics properties to allow them crossing the blood-brain barrier, hampering cholinesterase reactivation at the central nervous system. In this work, we design  ...[more]

Similar Datasets

| S-EPMC5610744 | biostudies-literature
| S-EPMC6151989 | biostudies-literature
| S-EPMC9655101 | biostudies-literature
| S-EPMC11202142 | biostudies-literature
| S-EPMC10620963 | biostudies-literature
| S-EPMC9215125 | biostudies-literature
| S-EPMC8621217 | biostudies-literature
| S-EPMC10731658 | biostudies-literature
| S-EPMC6843506 | biostudies-literature
| S-EPMC11348465 | biostudies-literature